Prostate Cancer Blood Test Reduces Rate of False Positives
The Prostate Health Index from Beckman Coulter Diagnostics minimizes the need for men with elevated PSA levels to undergo biopsy to achieve an accurate diagnosis.
Read MorePosted by Jenny Lower | Apr 28, 2014 | Cancer, Prostate |
The Prostate Health Index from Beckman Coulter Diagnostics minimizes the need for men with elevated PSA levels to undergo biopsy to achieve an accurate diagnosis.
Read MorePosted by Steve Halasey | Feb 25, 2014 | Research |
A newly published study of a molecular diagnostic test by Myriad Genetics has demonstrated that the test can accurately predict which men will develop biochemical recurrence or metastatic disease following radical prostate surgery.
Read MorePosted by Judy O'Rourke | Sep 26, 2013 | Cancer, Molecular Diagnostics, Prostate, Urinalysis & Toxicology |
A new ultraspecific urine test for prostate cancer is available. The test improves upon PSA test, increases ability to differentiate high-risk prostate tumors, and may cut unnecessary biopsies.
Read MorePosted by Judy O'Rourke | Aug 30, 2013 | Cancer, Molecular Diagnostics, Prostate, Research |
The research has implications for risk of hereditary and sporadic disease.
Read MorePosted by Judy O'Rourke | May 8, 2013 | Cancer, Miscellaneous, Research |
Decipher is a genomic test that provides a readout of the risk of metastatic disease for individual men with prostate cancer following radical prostatectomy that is independent of PSA and other risk factors.
Read More